| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |